Evidence map›Paper›PMID 36036625›Full record

ArticlemBio2022

CD55 Facilitates Immune Evasion by Borrelia crocidurae, an Agent of Relapsing Fever.

Gunjan Arora, Geoffrey E Lynn, Xiaotian Tang, Connor E Rosen, Dieuwertje Hoornstra, Andaleeb Sajid, Joppe W Hovius, Noah W Palm, Aaron M Ring, Erol Fikrig

Open access · goldAbstract read
In one paragraph

Article in mBio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Gunjan Arora *Section of Infectious Diseases, Department of Internal Medicine, Yale Universitygrid.47100.32 School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0003-0575-6205
Geoffrey E Lynn *Section of Infectious Diseases, Department of Internal Medicine, Yale Universitygrid.47100.32 School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0002-7095-0912
Xiaotian TangSection of Infectious Diseases, Department of Internal Medicine, Yale Universitygrid.47100.32 School of Medicine, New Haven, Connecticut, USA.
Connor E RosenDepartment of Immunobiology, Yale Universitygrid.47100.32 School of Medicine, New Haven, Connecticut, USA.
Dieuwertje HoornstraAmsterdam UMC, University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam Infection and Immunity, Amsterdam, Netherlands.ORCID 0000-0003-0347-2049
Andaleeb SajidSection of Infectious Diseases, Department of Internal Medicine, Yale Universitygrid.47100.32 School of Medicine, New Haven, Connecticut, USA.
Joppe W HoviusAmsterdam UMC, University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam Infection and Immunity, Amsterdam, Netherlands.
Noah W PalmDepartment of Immunobiology, Yale Universitygrid.47100.32 School of Medicine, New Haven, Connecticut, USA.
Aaron M RingDepartment of Immunobiology, Yale Universitygrid.47100.32 School of Medicine, New Haven, Connecticut, USA.
Erol FikrigSection of Infectious Diseases, Department of Internal Medicine, Yale Universitygrid.47100.32 School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0002-5884-6047
Yale University · USAmsterdam University Medical Centers · NL

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Tick Resources CoreP01AI138949 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI Erol Fikrig, UTPAL PAL · 2018 to 2026
$13.5M
The role of tick gut microbiota in Borrelia burgdorferi transmission to miceR01AI126033 · NIAID · YALE UNIVERSITY · PI FIKRIG, EROL, NARASIMHAN, SUKANYA · 2017 to 2020
$1.7M
A therapeutic for Lyme disease based on Peptidoglycan Recognition Protein 1R41AI157014 · NIAID · L2 DIAGNOSTICS, LLC · PI NARASIMHAN, SUKANYA · 2021 to 2022
$599k
NCATS NIH HHS UL1 TR001863NIAID NIH HHS P01 AI138949NIAID NIH HHS R01 AI126033NIAID NIH HHS R41 AI157014
6 · The paper itself

Abstract

Relapsing fever, caused by diverse Borrelia spirochetes, is prevalent in many parts of the world and causes significant morbidity and mortality. To investigate the pathoetiology of relapsing fever, we performed a high-throughput screen of Borrelia-binding host factors using a library of human extracellular and secretory proteins and identified CD55 as a novel host binding partner of Borrelia crocidurae and Borrelia persica, two agents of relapsing fever in Africa and Eurasia. CD55 is present on the surface of erythrocytes, carries the Cromer blood group antigens, and protects cells from complement-mediated lysis. Using flow cytometry, we confirmed that both human and murine CD55 bound to B. crocidurae and B. persica. Given the expression of CD55 on erythrocytes, we investigated the role of CD55 in pathological B. crocidurae-induced erythrocyte aggregation (rosettes), which enables spirochete immune evasion. We showed that rosette formation was partially dependent on host cell CD55 expression. Pharmacologically, soluble recombinant CD55 inhibited erythrocyte rosette formation. Finally, CD55-deficient mice infected with B. crocidurae had a lower pathogen load and elevated proinflammatory cytokine and complement factor C5a levels. In summary, our results indicate that CD55 is a host factor that is manipulated by the causative agents of relapsing fever for immune evasion.

Indexed as

Blood Group AntigensBorreliaRelapsing FeverAnimalsCytokinesHumansImmune EvasionMiceRodentiaBlood Group AntigensCytokineshost-pathogen interactionshost responseimmunopathogenesisrelapsing fever

Identifiers

PMID36036625
PMCPMC9600505
OpenAlexW4293447250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.